i agree... i still hold MBP, but am becoming more and more...

i agree... i still hold MBP, but am becoming more and more cautious with this one as time goes by. I do still think there is limited downside at this price... but now the market is also focusing on ACV1 as a more probable bet to commercialisation than AOD9604 given its market. This will temporise things until we have the results of the dose finding trial for AOD9604 in Mar 2007. and if positive.. a big pharma deal and phase III to commence... long way to go with this one...